Drugs / Cis-UCA
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 21 trial | ||||||
| Phase 2 | NCT01320579 | Mar 2011 → Jun 2012 | atopic eczema | BioCis Pharma Ltd | Completed | No outcome recorded |
| Comparator or background therapy1 trial | ||||||
| Phase 2 | NCT02326090 Comparator | Dec 2014 → Apr 2015 | dry eye syndrome | Herantis Pharma Plc. | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | cis-UCA | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02326090 ↗ |
| Route | Topical | “applied topically as a thin layer on the affected skin area” NCT01320579 ↗ |